Induction of β-Cell Replication by a Synthetic HNF4α Antagonist

Stem Cells

Volumn 31, Issue 11, 2013, Pages 2396-2407

  Lee, Seung Hee ^a   Piran, Ron ^a   Keinan, Ehud ^a   Pinkerton, Anthony ^b   Levine, Fred ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

^b BURNHAM INSTITUTE   (United States)

Author keywords

Beta cells; Diabetes mellitus; Islet of Langerhans; Regeneration; Replication

Indexed keywords

BI 6015; HEPATOCYTE NUCLEAR FACTOR 4ALPHA; PROTEIN INHIBITOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL COUNT; CELL DIVISION; CELL PROLIFERATION; CONTROLLED STUDY; DRUG EFFECT; MALE; MOUSE; NONHUMAN; PANCREAS ISLET BETA CELL;

MUS; ORYCTOLAGUS CUNICULUS;

BETA-CELLS; DIABETES MELLITUS; ISLET OF LANGERHANS; REGENERATION; REPLICATION;

ANIMALS; CELL GROWTH PROCESSES; DIABETES MELLITUS, EXPERIMENTAL; HEP G2 CELLS; HEPATOCYTE NUCLEAR FACTOR 4; HUMANS; INSULIN-SECRETING CELLS; ISLETS OF LANGERHANS; MALE; MICE; MICE, INBRED ICR; OLEIC ACID; PALMITIC ACIDS; RABBITS; RANDOM ALLOCATION;

EID: 84887899719     PISSN: 10665099     EISSN: None     Source Type: Journal    
DOI: 10.1002/stem.1496     Document Type: Article

References (61)

1. Butler PC, Meier JJ, Butler AE et al. The replication of beta cells in normal physiology, in disease and for therapy. Nat Clin Pract Endocri-nol Metab 2007; 3: 758-768. (Pubitemid 47622601)
2. Cozar-Castellano I., Fiaschi-Taesch N, Bigatel TA et al. Molecular control of cell cycle progression in the pancreatic beta-cell. Endocr Rev 2006; 27: 356-370. (Pubitemid 43848303)
3. Lee SH, Hao E, Levine F. Beta-cell replication and islet neogenesis following partial pancreatectomy. Islets 2011; 3: 188-195.
4. Dor Y, Brown J, Martinez OI et al. Adult pancreatic beta-cells are formed by self-duplication rather than stem-cell differentiation. Nature 2004; 429: 41-46. (Pubitemid 38620543)
5. Chung CH, Hao E, Piran R et al. Pancreatic beta-cell neogenesis by direct conversion from mature alpha-cells. Stem Cells 2010; 28: 1630-1638.
6. Rankin MM, Kushner JA. Adaptive beta-cell proliferation is severely restricted with advanced age. Diabetes 2009; 58: 1365-1372.
7. Teta M, Long SY, Wartschow LM et al. Very slow turnover of beta-cells in aged adult mice. Diabetes 2005; 54: 2557-2567. (Pubitemid 41233576)
8. Perl S, Kushner JA, Buchholz BA et al. Significant human beta-cell turnover is limited to the first three decades of life as determined by in vivo thymidine analog incorporation and radiocarbon dating. J Clin Endocrinol Metab 2010; 95:E234-239.
9. Lee SH, Itkin-Ansari P, Levine F. CENP-A, a protein required for chromosome segregation in mitosis, declines with age in islet but not exocrine cells. Aging (Albany Ny) 2010; 2: 785-790.
10. Cnop M, Hughes SJ, Igoillo-Esteve M et al. The long lifespan and low turnover of human islet beta cells estimated by mathematical modelling of lipofuscin accumulation. Diabetologia 2010; 53: 321-330.
11. Keenan HA, Sun JK, Levine J et al. Residual insulin production and pancreatic ss-cell turnover after 50 years of diabetes: Joslin Medalist Study. Diabetes 2010; 59: 2846-2853.
12. Butler AE, Janson J, Bonner-Weir S et al. Beta-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetes. Diabetes 2003; 52: 102-110. (Pubitemid 36042113)
13. Garcia-Ocana A., Takane KK, Reddy VT et al. Adenovirus-mediated hepatocyte growth factor expression in mouse islets improves pancreatic islet transplant performance and reduces beta cell death. J Biol Chem 2003; 278: 343-351. (Pubitemid 36043582)
14. Nielsen JH, Svensson C, Galsgaard ED et al. Beta cell proliferation and growth factors. J Mol Med 1999; 77: 62-66. (Pubitemid 29146184)
15. Kim H, Toyofuku Y, Lynn FC et al. Serotonin regulates pancreatic beta cell mass during pregnancy. Nat Med 2010; 16: 804-808.
16. Xu G, Stoffers DA, Habener JF et al. Exendin-4 stimulates both beta-cell replication and neogenesis, resulting in increased beta-cell mass and improved glucose tolerance in diabetic rats. Diabetes 1999; 48: 2270-2276. (Pubitemid 30395416)
17. Porat S, Weinberg-Corem N, Tornovsky-Babaey S et al. Control of pancreatic beta cell regeneration by glucose metabolism. Cell Metab 2011; 13: 440-449.
18. Annes JP, Ryu JH, Lam K et al. Adenosine kinase inhibition selectively promotes rodent and porcine islet beta-cell replication. Proc Natl Acad Sci USA 2012; 109: 3915-3920.
19. Andersson O, Adams BA, Yoo D et al. Adenosine signaling promotes regeneration of pancreatic beta cells in vivo. Cell Metab 2012; 15: 885-894.
20. Yi P, Park JS, Melton DA. Betatrophin: A hormone that controls pancreatic beta cell proliferation. Cell 2013; 153: 747-758.
21. Esterhazy D, Stutzer I, Wang H et al. Bace2 is a beta cell-enriched protease that regulates pancreatic beta cell function and mass. Cell Metab 2011; 14: 365-377.
22. Kiselyuk A, Lee SH, Farber-Katz S et al. HNF4αlpha antagonists discovered by a high-throughput screen for modulators of the human insulin promoter. Chem Biol 2012; 19: 806-818.
23. Overington JP, Al-Lazikani B, Hopkins AL. How many drug targets are there? Nat Rev Drug Discov 2006; 5: 993-996. (Pubitemid 44835126)
24. Stoffel M, Duncan SA. The maturity-onset diabetes of the young (MODY1) transcription factor HNF4αlpha regulates expression of genes required for glucose transport and metabolism. Proc Natl Acad Sci USA 1997; 94: 13209-13214. (Pubitemid 27518501)
25. Gupta RK, Gao N, Gorski RK et al. Expansion of adult beta-cell mass in response to increased metabolic demand is dependent on HNF-4alpha. Genes Dev 2007; 21: 756-769. (Pubitemid 46572356)
26. Rieck S, Zhang J, Li Z et al. Overexpression of hepatocyte nuclear factor-4alpha initiates cell cycle entry, but is not sufficient to promote beta-cell expansion in human islets. Mol Endocrinol 2012; 26: 1590-1602.
27. Hayhurst GP, Lee YH, Lambert G et al. Hepatocyte nuclear factor 4alpha (nuclear receptor 2A1) is essential for maintenance of hepatic gene expression and lipid homeostasis. Mol Cell Biol 2001; 21: 1393-1403. (Pubitemid 32114986)
28. Bonzo JA, Ferry CH, Matsubara T et al. Suppression of hepatocyte proliferation by hepatocyte nuclear factor 4alpha in adult mice. J Biol Chem 2012; 287: 7345-7356.
29. Yuan X, Ta TC, Lin M et al. Identification of an endogenous ligand bound to a native orphan nuclear receptor. PLoS One 2009; 4:e5609.
30. Dhe-Paganon S., Duda K, Iwamoto M et al. Crystal structure of the HNF4 alpha ligand binding domain in complex with endogenous fatty acid ligand. J Biol Chem 2002; 277: 37973-37976. (Pubitemid 35154647)
31. Hull RL, Kodama K, Utzschneider KM et al. Dietary-fat-induced obesity in mice results in beta cell hyperplasia but not increased insulin release: Evidence for specificity of impaired beta cell adaptation. Dia-betologia 2005; 48: 1350-1358. (Pubitemid 41186101)
32. Kiselyuk A, Farber-Katz S, Cohen T et al. Phenothiazine neuroleptics signal to the human insulin promoter as revealed by a novel high-throughput screen. J Biomol Screen 2010; 15: 663-670.
33. Bailly A, Torres-Padilla ME, Tinel AP et al. An enhancer element 6 kb upstream of the mouse HNF4αlpha1 promoter is activated by glu-cocorticoids and liver-enriched transcription factors. Nucleic Acids Res 2001; 29: 3495-3505. (Pubitemid 32898763)
34. Lee SH, Hao E, Levine F et al. Id3 upregulates BrdU incorporation associated with a DNA damage response, not replication, in human pancreatic beta-cells. Islets 2011; 3: 358-366.
35. Rankin MM, Kushner JA. Aging induces a distinct gene expression program in mouse islets. Islets 2010; 2: 345-352.
36. Fiaschi-Taesch N., Bigatel TA, Sicari B et al. Survey of the human pancreatic beta cell G1/S proteome reveals a potential therapeutic role for Cdk-6 and Cyclin D1 in enhancing human beta cell replication and function in vivo. Diabetes 2009; 58: 882-893.
37. Sherr CJ, Roberts JM. CDK inhibitors: Positive and negative regulators of G1-phase progression. Genes Dev 1999; 13: 1501-1512. (Pubitemid 29297917)
38. Kassem SA, Ariel I, Thornton PS et al. p57(KIP2) expression in normal islet cells and in hyperinsulinism of infancy. Diabetes 2001; 50: 2763-2769. (Pubitemid 33733127)
39. Krishnamurthy J, Ramsey MR, Ligon KL et al. p16INK4a induces an age-dependent decline in islet regenerative potential. Nature 2006; 443: 453-457. (Pubitemid 44477281)
40. Kohler CU, Olewinski M, Tannapfel A et al. Cell cycle control of beta-cell replication in the prenatal and postnatal human pancreas. Am J Physiol Endocrinol Metab 2011; 300:E221-230.
41. Miyazaki J, Araki K, Yamato E et al. Establishment of a pancreatic beta cell line that retains glucose-inducible insulin secretion: Special reference to expression of glucose transporter isoforms. Endocrinology 1990; 127: 126-132. (Pubitemid 20228111)
42. Guo Y, Harwalkar J, Stacey DW et al. Destabilization of cyclin D1 message plays a critical role in cell cycle exit upon mitogen withdrawal. Oncogene 2005; 24: 1032-1042. (Pubitemid 40313880)
43. Nishimura W, Kondo T, Salameh T et al. A switch from MafB to MafA expression accompanies differentiation to pancreatic beta-cells. Dev Biol 2006; 293: 526-539.
44. Doyle MJ, Sussel L. Nkx2.2 regulates beta-cell function in the mature islet. Diabetes 2007; 56: 1999-2007. (Pubitemid 47195826)
45. Lu J, Hamze Z, Bonnavion R et al. Reexpression of oncoprotein MafB in proliferative beta-cells and Men1 insulinomas in mouse. Oncogene 2012; 31: 3647-3654.
46. Wang J, Wan R, Mo Y et al. Creating a long-term diabetic rabbit model. Exp Diabetes Res 2010; 2010: 289614.
47. Duranthon V, Beaujean N, Brunner M et al. On the emerging role of rabbit as human disease model and the instrumental role of novel transgenic tools. Transgenic Res 2012; 21: 699-713.
48. Fiaschi-Taesch N.M., Salim F, Kleinberger J et al. Induction of human beta-cell proliferation and engraftment using a single G1/S regulatory molecule, cdk6. Diabetes 2010; 59: 1926-1936.
49. Miura A, Yamagata K, Kakei M et al. Hepatocyte nuclear factor-4alpha is essential for glucose-stimulated insulin secretion by pancreatic beta-cells. J Biol Chem 2006; 281: 5246-5257. (Pubitemid 43847789)
50. Walesky C, Gunewardena S, Terwilliger EF et al. Hepatocyte-specific deletion of hepatocyte nuclear factor-4alpha in adult mice results in increased hepatocyte proliferation. Am J Physiol Gastrointest Liver Physiol 2013; 304:G26-37.
51. Boyd M, Bressendorff S, Moller J et al. Mapping of HNF4αlpha target genes in intestinal epithelial cells. BMC Gastroenterol 2009; 9: 68.
52. Odom DT, Dowell RD, Jacobsen ES et al. Tissue-specific transcriptional regulation has diverged significantly between human and mouse. Nat Genet 2007; 39: 730-732. (Pubitemid 46848594)
53. Odom DT, Zizlsperger N, Gordon DB et al. Control of pancreas and liver gene expression by HNF transcription factors. Science 2004; 303: 1378-1381. (Pubitemid 38269432)
54. Li J, Poi MJ, Tsai MD. Regulatory mechanisms of tumor suppressor P16(INK4A) and their relevance to cancer. Biochemistry 2011; 50: 5566-5582.
55. Takahashi E, Funato N, Higashihori N et al. Snail regulates p21(WAF/CIP1) expression in cooperation with E2A and Twist. Biochem Bio-phys Res Commun 2004; 325: 1136-1144. (Pubitemid 39535882)
56. Wang X, Pan L, Feng Y et al. P300 plays a role in p16(INK4a) expression and cell cycle arrest. Oncogene 2008; 27: 1894-1904. (Pubitemid 351430815)
57. Figliola R, Busanello A, Vaccarello G et al. Regulation of p57(KIP2) during muscle differentiation: Role of Egr1, Sp1 and DNA hypomethylation. J Mol Biol 2008; 380: 265-277.
58. Hwang-Verslues W.W., Sladek FM. Nuclear receptor hepatocyte nuclear factor 4alpha1 competes with oncoprotein c-Myc for control of the p21/WAF1 promoter. Mol Endocrinol 2008; 22: 78-90.
59. Chiba H, Gotoh T, Kojima T et al. Hepatocyte nuclear factor (HNF)-4alpha triggers formation of functional tight junctions and establishment of polarized epithelial morphology in F9 embryonal carcinoma cells. Exp Cell Res 2003; 286: 288-297. (Pubitemid 36566441)
60. Nikolaidou-Neokosmidou V., Zannis VI, Kardassis D. Inhibition of hepatocyte nuclear factor 4 transcriptional activity by the nuclear factor kappaB pathway. Biochem J 2006; 398: 439-450. (Pubitemid 44453388)
61. Butler AE, Robertson RP, Hernandez R et al. Beta cell nuclear muscu-loaponeurotic fibrosarcoma oncogene family A (MafA) is deficient in type 2 diabetes. Diabetologia 2012; 55: 2985-2988.